Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1964 1
1966 1
1967 1
1968 2
1969 1
1973 1
1974 1
1975 9
1976 9
1977 10
1978 6
1979 11
1980 12
1981 14
1982 11
1983 12
1984 19
1985 18
1986 24
1987 22
1988 39
1989 40
1990 40
1991 34
1992 52
1993 49
1994 69
1995 65
1996 73
1997 74
1998 80
1999 82
2000 59
2001 66
2002 85
2003 83
2004 101
2005 94
2006 103
2007 92
2008 116
2009 123
2010 136
2011 134
2012 171
2013 154
2014 153
2015 174
2016 173
2017 155
2018 141
2019 171
2020 144
2021 159
2022 154
2023 124
2024 43

Text availability

Article attribute

Article type

Publication date

Search Results

3,639 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Benign female reproductive system neoplasm"
Page 1
Gynecologic cancer in pregnancy.
Korenaga TK, Tewari KS. Korenaga TK, et al. Gynecol Oncol. 2020 Jun;157(3):799-809. doi: 10.1016/j.ygyno.2020.03.015. Epub 2020 Apr 5. Gynecol Oncol. 2020. PMID: 32268951 Free PMC article. Review.
Benign and malignant germ cell tumors and borderline tumors are occasionally encountered, with unilateral adnexectomy and preservation of the uterus and contralateral ovary being the rule. ...For gynecologic malignancies, pregnancy does not impart aggressive clinical behav …
Benign and malignant germ cell tumors and borderline tumors are occasionally encountered, with unilateral adnexectomy and preservatio …
Global burden of human papillomavirus and related diseases.
Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S. Forman D, et al. Vaccine. 2012 Nov 20;30 Suppl 5:F12-23. doi: 10.1016/j.vaccine.2012.07.055. Vaccine. 2012. PMID: 23199955 Review.
Cervical cancer, for which the PAF is estimated to be 100%, accounted for 530,000 (86.9%) of the HPV attributable cases with the other five cancer types accounting for the residual 80,000 cancers. Cervical cancer is the third most common female malignancy and shows a stron …
Cervical cancer, for which the PAF is estimated to be 100%, accounted for 530,000 (86.9%) of the HPV attributable cases with the other five …
Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.
Hauptmann S, Friedrich K, Redline R, Avril S. Hauptmann S, et al. Virchows Arch. 2017 Feb;470(2):125-142. doi: 10.1007/s00428-016-2040-8. Epub 2016 Dec 27. Virchows Arch. 2017. PMID: 28025670 Free PMC article. Review.
Borderline ovarian tumors (BOT) are uncommon but not rare epithelial ovarian neoplasms, intermediate between benign and malignant categories. Since BOT were first identified >40 years ago, they have inspired controversies disproportionate to their incidence. ...T …
Borderline ovarian tumors (BOT) are uncommon but not rare epithelial ovarian neoplasms, intermediate between benign and malign …
The tamoxifen controversy.
Crabbe WW. Crabbe WW. Oncol Nurs Forum. 1996 Jun;23(5):761-6. Oncol Nurs Forum. 1996. PMID: 8792346 Review.
PURPOSE/OBJECTIVES: To conduct a comprehensive review of the controversies associated with tamoxifen, specifically the increased incidence of benign conditions of the uterus and endometrial cancer, tamoxifen's common side effects, the Breast Cancer Prevention Trial, and sc …
PURPOSE/OBJECTIVES: To conduct a comprehensive review of the controversies associated with tamoxifen, specifically the increased incidence o …
Circulating tumor cells in gynaecological malignancies.
Kiss I, Kolostova K, Pawlak I, Bobek V. Kiss I, et al. J BUON. 2020 Jan-Feb;25(1):40-50. J BUON. 2020. PMID: 32277613 Review.
In this review we concentrate on gynecological malignancies and how CTCs could be used in the diagnosis of cancer, treatment management and its effective prognosis and early recurrence detection. Presence of CTCs in endometrial cancer patients show worse overall survival, …
In this review we concentrate on gynecological malignancies and how CTCs could be used in the diagnosis of cancer, treatment management and …
Indications for morcellation in gynecologic surgery.
Parker WH. Parker WH. Curr Opin Obstet Gynecol. 2018 Feb;30(1):75-80. doi: 10.1097/GCO.0000000000000427. Curr Opin Obstet Gynecol. 2018. PMID: 29251677 Review.
SUMMARY: Morcellation of excised tissue is necessary for many women with symptomatic fibroids who choose to undergo laparoscopic myomectomy or hysterectomy. LMS is an uncommon disease, with a poor prognosis due to early hematogenous metastasis to lung, bone and liver. Preo …
SUMMARY: Morcellation of excised tissue is necessary for many women with symptomatic fibroids who choose to undergo laparoscopic myomectomy …
Uterine Adenosarcoma: a Review.
Nathenson MJ, Ravi V, Fleming N, Wang WL, Conley A. Nathenson MJ, et al. Curr Oncol Rep. 2016 Nov;18(11):68. doi: 10.1007/s11912-016-0552-7. Curr Oncol Rep. 2016. PMID: 27718181 Review.
Adenosarcomas are rare malignancies of the female genital tract, accounting for approximately 5 % of uterine sarcomas. Occasionally, adenosarcoma occurs in the ovaries or in extra-uterine tissue, which may be related to endometriosis. These tumors are characterized …
Adenosarcomas are rare malignancies of the female genital tract, accounting for approximately 5 % of uterine sarcomas. Occasio …
Gestational trophoblastic disease- rare, sometimes dramatic, and what we know so far.
Strickland AL, Gwin K. Strickland AL, et al. Semin Diagn Pathol. 2022 May;39(3):228-237. doi: 10.1053/j.semdp.2022.03.002. Epub 2022 Mar 22. Semin Diagn Pathol. 2022. PMID: 35400536 Review.
The recently updated 2020 World Health Organization (WHO) Classification of Female Genital Tumors divides GTD in molar pregnancies/ hydatidiform moles, gestational trophoblastic neoplasms, tumor-like lesions and abnormal (nonmolar) villous lesions. ...We disc …
The recently updated 2020 World Health Organization (WHO) Classification of Female Genital Tumors divides GTD in molar pregnan …
Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances.
Levy G, Hill MJ, Beall S, Zarek SM, Segars JH, Catherino WH. Levy G, et al. J Assist Reprod Genet. 2012 Aug;29(8):703-12. doi: 10.1007/s10815-012-9784-0. Epub 2012 May 15. J Assist Reprod Genet. 2012. PMID: 22584729 Free PMC article. Review.
PURPOSE: Uterine leiomyomas are common, benign, reproductive tract tumors affecting a majority of reproductive aged women. They are associated with gynecologic morbidity and detrimentally affect reproductive potential. The etiology of leiomyomas is poo …
PURPOSE: Uterine leiomyomas are common, benign, reproductive tract tumors affecting a majority of reproductive aged wom …
Evaluation of occult uterine leiomyosarcomas.
Beyan E, Kanmaz AG, İnan AH, Karataşlı V, Tutar SO, Alan M, Töz E, Sancı M. Beyan E, et al. Ginekol Pol. 2019;90(8):433-437. doi: 10.5603/GP.2019.0075. Ginekol Pol. 2019. PMID: 31482545 Free article.
OBJECTIVES: To determine the frequency of occult uterine leiomyosarcomas following hysterectomies and myomectomiesperformed for benign reasons at our clinic and to draw comparisons with similar studies in the literature. MATERIAL AND METHODS: All hysterectomies and myomect …
OBJECTIVES: To determine the frequency of occult uterine leiomyosarcomas following hysterectomies and myomectomiesperformed for benign …
3,639 results